<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Atypon//DTD Atypon Systems Journal Archiving and Interchange NLM DTD v3.0.6 20130326//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName atypon-archivearticle3.dtd?>
<?SourceDTD.Version 3.0.6?>
<?ConverterInfo.XSLTName atyponoasis-oasisns2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Big Data</journal-id>
    <journal-id journal-id-type="iso-abbrev">Big Data</journal-id>
    <journal-id journal-id-type="publisher-id">big</journal-id>
    <journal-title-group>
      <journal-title>Big Data</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">2167-6461</issn>
    <issn pub-type="epub">2167-647X</issn>
    <publisher>
      <publisher-name>Mary Ann Liebert, Inc.</publisher-name>
      <publisher-loc>140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4932659</article-id>
    <article-id pub-id-type="publisher-id">10.1089/big.2015.0057</article-id>
    <article-id pub-id-type="doi">10.1089/big.2015.0057</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Articles</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Integration and Visualization of Translational Medicine Data for Better Understanding of Human Diseases</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Satagopam</surname>
          <given-names>Venkata</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1,</sup>
        </xref>
        <xref ref-type="corresp" rid="corr1">
          <sup>*</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gu</surname>
          <given-names>Wei</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Eifes</surname>
          <given-names>Serge</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1,</sup>
        </xref>
        <xref ref-type="aff" rid="aff2">
          <sup>2</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gawron</surname>
          <given-names>Piotr</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ostaszewski</surname>
          <given-names>Marek</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gebel</surname>
          <given-names>Stephan</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Barbosa-Silva</surname>
          <given-names>Adriano</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Balling</surname>
          <given-names>Rudi</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Schneider</surname>
          <given-names>Reinhard</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <aff id="aff1"><label><sup>1</sup></label>Luxembourg Centre for Systems Biomedicine, <institution>University of Luxembourg</institution>, Esch-Belval, <country>Luxembourg</country>.</aff>
      <aff id="aff2"><label><sup>2</sup></label><institution>Information Technology for Translational Medicine (ITTM) S.A.</institution>, Esch-Belval, <country>Luxembourg</country>.</aff>
    </contrib-group>
    <author-notes>
      <corresp id="corr1"><label><sup>*</sup></label>Address correspondence to: <italic>Venkata Satagopam, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7, Avenue des Hauts-Fourneaux, Esch-Belval L-4362, Luxembourg,</italic> E-mail: <email xlink:href="mailto:venkata.satagopam@uni.lu">venkata.satagopam@uni.lu</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>01</day>
      <month>6</month>
      <year>2016</year>
      <!--string-date: June 2016-->
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>01</day>
      <month>6</month>
      <year>2016</year>
      <!--string-date: June 2016-->
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="ppub"/>. -->
    <volume>4</volume>
    <issue>2</issue>
    <fpage>97</fpage>
    <lpage>108</lpage>
    <permissions>
      <copyright-statement>© Venkata Satagopam <italic>et al.</italic> 2016; Published by Mary Ann Liebert, Inc.</copyright-statement>
      <copyright-year>2016</copyright-year>
      <license license-type="open-access">
        <license-p>This Open Access article is distributed under the terms of the Creative Commons License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:type="simple" xlink:href="big.2015.0057.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Translational medicine is a domain turning results of basic life science research into new tools and methods in a clinical environment, for example, as new diagnostics or therapies. Nowadays, the process of translation is supported by large amounts of heterogeneous data ranging from medical data to a whole range of -omics data. It is not only a great opportunity but also a great challenge, as translational medicine big data is difficult to integrate and analyze, and requires the involvement of biomedical experts for the data processing. We show here that visualization and interoperable workflows, combining multiple complex steps, can address at least parts of the challenge. In this article, we present an integrated workflow for exploring, analysis, and interpretation of translational medicine data in the context of human health. Three Web services—tranSMART, a Galaxy Server, and a MINERVA platform—are combined into one big data pipeline. Native visualization capabilities enable the biomedical experts to get a comprehensive overview and control over separate steps of the workflow. The capabilities of tranSMART enable a flexible filtering of multidimensional integrated data sets to create subsets suitable for downstream processing. A Galaxy Server offers visually aided construction of analytical pipelines, with the use of existing or custom components. A MINERVA platform supports the exploration of health and disease-related mechanisms in a contextualized analytical visualization system. We demonstrate the utility of our workflow by illustrating its subsequent steps using an existing data set, for which we propose a filtering scheme, an analytical pipeline, and a corresponding visualization of analytical results. The workflow is available as a sandbox environment, where readers can work with the described setup themselves. Overall, our work shows how visualization and interfacing of big data processing services facilitate exploration, analysis, and interpretation of translational medicine data.</p>
    </abstract>
    <kwd-group kwd-group-type="author">
      <title><bold>Key words:</bold> </title>
      <kwd>big data analytics</kwd>
      <kwd>big data infrastructure design</kwd>
      <kwd>data acquisition and cleaning</kwd>
      <kwd>data integration</kwd>
      <kwd>data mining</kwd>
      <kwd>disease map</kwd>
    </kwd-group>
    <counts>
      <fig-count count="4"/>
      <ref-count count="99"/>
      <page-count count="12"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="s001">
    <title>Introduction</title>
    <p>Translational medicine capitalizes on advances in basic life sciences to improve clinical research and care. We witness great technological advances in methods characterizing human health and disease, including genetic and environmental factors of our well-being. This is a great opportunity to understand diseases and to find new diagnoses and treatments. However, the progress comes at a cost—translational research data sets nowadays include genomic, imaging, and clinical data sources,<sup><xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref></sup> making them large and heterogeneous. In effect, important steps of the data life cycle in discovery—integration, analysis, and interpretation—are a challenge for biomedical research. Moreover, enabling biomedical experts to efficiently use big data processing pipelines is another challenge.</p>
    <p>As translational medicine data become more and more rich and complex, their potential in informing both clinical and basic research grows.<sup><xref rid="B3" ref-type="bibr">3</xref></sup> With constantly increasing presence of high-throughput molecular profiling, it becomes increasingly important to ensure that data interpretation capabilities follow generation of large-scale biomedical data sets.<sup><xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref></sup> Visualization can support greatly the processing of complex data sets on each of the steps of the data life cycle. This opportunity is actively explored in various domains of biomedical research, including clinical big data<sup><xref rid="B6" ref-type="bibr">6</xref></sup> or multiscale biomedical ontologies.<sup><xref rid="B7" ref-type="bibr">7</xref></sup></p>
    <p>Modern translational medicine approaches aim to combine clinical and molecular profiles of the patients to formulate informed hypothesis on the basis of stratified data.<sup><xref rid="B8" ref-type="bibr">8</xref></sup> Integration of plethora of sources renders these data sets complex and difficult to process. Visualization of such integrated data sets can aid exploration and selection of key dimensions and subsets for downstream analysis. In turn, visually aided data analysis allows to comprehend even complicated workflows and aids interpretation of resulting data.</p>
    <p>In this article, we demonstrate a workflow for translational medicine big data, in which visualization is an important component at each step of data processing and exploration. We describe in detail the interfaces allowing the construction of the workflow, followed up by a use case scenario. We conclude with a discussion of the results and an outlook for future development of visualization in biomedical big data exploration.</p>
  </sec>
  <sec id="s002">
    <title>Related Work</title>
    <sec id="s003">
      <title>Clinical and molecular (omics) data integration platforms</title>
      <p>The rise of personalized medicine and the availability of high-throughput molecular analysis drives the development of storage, analytics, and interpretive methods to enable the transformation of increasingly voluminous biomedical data into proactive, predictive, preventative, and participatory healthcare.<sup><xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref></sup> Key properties of biomedical big data in translational medicine, according to the “5V” classification,<sup><xref rid="B11" ref-type="bibr">11</xref></sup> besides its volume are variety and veracity. A combination of clinical<xref ref-type="fn" rid="fn1">*</xref> and high-throughput molecular profiles (“omics”)<sup><xref ref-type="fn" rid="fn2">†</xref></sup> creates a very variable heterogeneous data set, where dimensionalities of different data types span several orders of magnitude.<sup><xref rid="B12" ref-type="bibr">12</xref></sup> Moreover, ensuring veracity, that is, quality, to clinical data is a challenging and time-consuming task.<sup><xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B14" ref-type="bibr">14</xref></sup> This stems from a variety of collection methods, featuring manual data input, nondigital data capture, and nonstandard formats. It needs to be stressed that proper data curation is a mandatory step for accurate analysis of clinical data and proper interpretation of analytical results.</p>
      <p>The emergence of big biomedical data sets, covering dozens of thousands of patients,<sup><xref rid="B12" ref-type="bibr">12</xref></sup> raises questions on infrastructure necessary to host and analyze them. Especially genomic data, generated rapidly due to dropping sequencing costs, pose a problem in terms of storage and analytics. The perspective of cloud computing is postulated as a solution to this challenge, as summarized in recent and extensive reviews.<sup><xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref></sup> Nevertheless, due to ethical and legal issues arising in cloud-based scenarios,<sup><xref rid="B17" ref-type="bibr">17</xref></sup> incorporation of clinical data and processing of sensitive omics are still considered an open question.</p>
      <p>Translational medicine platforms integrating clinical and omics data need to ensure a protected environment for sensitive data processing. A number of solutions were developed to address this challenge, as summarized in an excellent review by Canuel et al.<sup><xref rid="B18" ref-type="bibr">18</xref></sup> Platforms integrating clinical and omics data can be divided into two groups: repositories with an existing infrastructure and solutions requiring deployment. The first group is represented by technologies, such as STRIDE,<sup><xref rid="B19" ref-type="bibr">19</xref></sup> iDASH,<sup><xref rid="B20" ref-type="bibr">20</xref></sup> caGRID, and its follow-up, TRIAD<sup><xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref></sup> or BDDS Center.<sup><xref rid="B23" ref-type="bibr">23</xref></sup> Certain platforms of this group focus on a specific disease, such as cBioPortal<sup><xref rid="B24" ref-type="bibr">24</xref></sup> or G-DOC<sup><xref rid="B25" ref-type="bibr">25</xref></sup> for cancer or COPD Knowledge Base<sup><xref rid="B26" ref-type="bibr">26</xref></sup> for pulmonary dysfunction. The advantage of solutions based on existing computational infrastructure is direct use but at the cost of reduced flexibility in configuration and toolset management. The other group of solutions for translational medicine requires deployment on the user's infrastructure, often requiring substantial storage or high-performance computing (HPC) capabilities. Notable examples in this group are BRISK,<sup><xref rid="B27" ref-type="bibr">27</xref></sup> tranSMART,<sup><xref rid="B28" ref-type="bibr">28</xref></sup> and Transmed.<sup><xref rid="B29" ref-type="bibr">29</xref></sup> Because of their highly configurable nature, such solutions are suitable in projects implicating sensitive data, and where a repository is needed to support ongoing projects, such as in case of longitudinal cohort<sup><xref ref-type="fn" rid="fn3">‡</xref></sup> studies. Informative use cases of such platforms are SHRINE<sup><xref rid="B30" ref-type="bibr">30</xref></sup> and DARiS,<sup><xref rid="B31" ref-type="bibr">31</xref></sup> where well-defined demands of clinical research projects drove the design and implementation of infrastructure supporting translational medicine.</p>
      <p>Visually aided data exploration is an important component of clinical and omics integration platforms. A notable contributor in this field is the Informatics for Integrating Biology and the Bedside project (i2b2, <uri xlink:type="simple" xlink:href="http://www.i2b2.org">www.i2b2.org</uri>), a scalable framework enabling the use of clinical data for discovery research.<sup><xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref></sup> The i2b2 Hive<sup><xref rid="B34" ref-type="bibr">34</xref></sup> is a powerful collection of interoperable tools ranging from repository services to basic data conversions provided by i2b2 cells. Importantly, i2b2 Hive does not support directly the analysis of omics data, such as gene expression or whole-genome sequences by itself,<sup><xref rid="B35" ref-type="bibr">35</xref></sup> but enables key capabilities of clinical data exploration and processing to be used by other platforms.</p>
    </sec>
    <sec id="s004">
      <title>Bioinformatics workflow management systems</title>
      <p>Reusable and interoperable bioinformatics workflows become increasingly important in reproducible analysis of biomedical data and metadata, including clinical, omics, imaging, and sensor data.<sup><xref rid="B36" ref-type="bibr">36–38</xref></sup> A number of software frameworks were developed to support the scientific community in this goal. In a thorough review and classification of these workflow frameworks, Leipzig<sup><xref rid="B36" ref-type="bibr">36</xref></sup> groups existing technologies according to their interaction mode into command-line/application programming interface (API) and workbench approaches. The first group includes Snakemake,<sup><xref rid="B39" ref-type="bibr">39</xref></sup> Yabi,<sup><xref rid="B40" ref-type="bibr">40</xref></sup> Chipster,<sup><xref rid="B41" ref-type="bibr">41</xref></sup> or Mobyle<sup><xref rid="B42" ref-type="bibr">42</xref></sup> and relies on textual workflow construction in a script-like format. Certain tools in this group, such as Chipster, enable Web-based collaborative development of workflows.</p>
      <p>The second group of platforms provides the so-called “workbench environment”: a GUI enabling visually supported construction of workflows. Usually, workflows are represented as graphs, where nodes correspond to data processing steps, and edges to data flow. Workbench solutions include Galaxy,<sup><xref rid="B43" ref-type="bibr">43</xref></sup> Taverna,<sup><xref rid="B44" ref-type="bibr">44</xref></sup> Pipeline Pilot,<sup><xref rid="B45" ref-type="bibr">45</xref></sup> KNIME,<sup><xref rid="B46" ref-type="bibr">46</xref></sup> or gUSE.<sup><xref rid="B47" ref-type="bibr">47</xref></sup> Similar to data integration platforms, these tools need to be deployed on the user-provided infrastructure, and the extent of possible analysis is restrained by available storage and HPC capacities.</p>
      <p>Ensuring computational resources may be a challenging task, and cloud computing becomes increasingly more important paradigm in development and execution of bioinformatics workflows. Cloud-oriented workflow management systems offer API support for construction of an analytical pipeline, including open-access solutions, such as Agave<sup><xref rid="B48" ref-type="bibr">48</xref></sup> or Arvados,<sup><xref rid="B49" ref-type="bibr">49</xref></sup> or a number of commercial services.<sup><xref rid="B5" ref-type="bibr">5</xref></sup> Workbench platforms are also available in the computational cloud environment. Interestingly, a number of open-access solutions use Galaxy as a workflow construction engine, including Galaxy Cloud,<sup><xref rid="B50" ref-type="bibr">50</xref></sup> Tavaxy,<sup><xref rid="B51" ref-type="bibr">51</xref></sup> or Genomics Virtual Laboratory.<sup><xref rid="B38" ref-type="bibr">38</xref></sup> Commercial cloud workbenches, such as Seven Bridges (<uri xlink:type="simple" xlink:href="http://sbgenomics.com">http://sbgenomics.com</uri>), are also available. In summary, cloud computing is an attractive scalable option on demand, especially for multisite collaborative research projects in terms of bringing the tools to the data. However, the speed of data transfer to the cloud, flexibility of the configuration of analytical pipelines, and the issues of privacy and security in data analytics remain challenges to address.<sup><xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B36" ref-type="bibr">36</xref></sup></p>
    </sec>
    <sec id="s005">
      <title>Platforms for visualization of molecular interaction networks</title>
      <p>With the progress of systems biomedicine, molecular interaction networks<sup><xref ref-type="fn" rid="fn4">§</xref></sup> became a popular form of representing knowledge about molecular mechanisms pertinent to human health.<sup><xref rid="B52" ref-type="bibr">52</xref></sup> First, such networks provide a necessary format to encode multitude of interactions identified in biomedicine. Second, they provide a good support for visual exploration and analytics of complex knowledge.<sup><xref rid="B53" ref-type="bibr">53</xref></sup> As such, they have a great potential in aiding the interpretation of analytical outcomes of translational medicine pipelines.</p>
      <p>Molecular interaction networks can be constructed in various ways that determine their size and purpose. Experiment-derived networks are established from different types of molecular readouts, allowing, with a certain probability, ascertain physical interaction between molecules, for example, protein–protein interaction<sup><xref rid="B54" ref-type="bibr">54</xref></sup> or chromatin immunoprecipitation assays.<sup><xref rid="B55" ref-type="bibr">55</xref></sup> Analysis-inferred networks are constructed by analyzing high-throughput omics data to identify molecules with similar properties or behavior, for example, using coexpression analysis.<sup><xref rid="B56" ref-type="bibr">56</xref></sup> Finally, knowledge-based networks are established on the basis of existing body of knowledge, usually a set of published articles. Construction of knowledge-based networks is usually accomplished with text mining approaches<sup><xref rid="B57" ref-type="bibr">57</xref></sup> or expert curation.<sup><xref rid="B58" ref-type="bibr">58</xref>,<xref rid="B59" ref-type="bibr">59</xref></sup></p>
      <p>While experiment-derived and analysis-inferred networks offer a vast amount of unbiased information, they are usually large-scale graphs, requiring sophisticated network analysis to draw meaningful conclusions. Mapping translational medicine data sets on top of these networks may be considered an important step in the analysis<sup><xref rid="B60" ref-type="bibr">60</xref></sup> but not in the final interpretation of an analytical workflow. In turn, knowledge-based networks are usually established on the basis of low-throughput, in-depth experiments and allow for direct data interpretation. In particular, text mining networks are often used by the scientific community, where a number of commercial solutions, such as Ingenuity Pathway Analysis,<sup><xref rid="B61" ref-type="bibr">61</xref></sup> Pathway Studio,<sup><xref rid="B62" ref-type="bibr">62</xref></sup> or MetaCore,<sup><xref rid="B63" ref-type="bibr">63</xref></sup> offer already established databases. These solutions, however, tend to contain the entire discovery pipeline inside their platforms, greatly reducing data interoperability.</p>
      <p>Expert-curated networks are focused resources of high-quality confirmed knowledge and offer the highest degree of data set interpretation to translational medicine researchers. Important resources in the field of expert-curated networks are repositories called “pathway databases,” such as KEGG,<sup><xref rid="B64" ref-type="bibr">64</xref></sup> Reactome,<sup><xref rid="B65" ref-type="bibr">65</xref></sup> or WikiPathways,<sup><xref rid="B59" ref-type="bibr">59</xref></sup> which describe general biomolecular mechanisms. In contrast, the other type of networks focuses on representing mechanisms of human diseases as so-called “disease maps.”<sup><xref rid="B58" ref-type="bibr">58</xref>,<xref rid="B66" ref-type="bibr">66</xref>,<xref rid="B67" ref-type="bibr">67</xref></sup> Detailed representation of domain knowledge and support by domain-related literature makes disease maps a potentially interesting element of translational medicine analytical pipelines. Computational architectures supporting these maps provide dedicated APIs,<sup><xref rid="B68" ref-type="bibr">68</xref>,<xref rid="B69" ref-type="bibr">69</xref></sup> opening an interesting avenue in translational medicine data processing—from storage, through bioinformatics workflow analytics, to interpretation by visualization on the dedicated molecular interaction network.</p>
    </sec>
  </sec>
  <sec id="s006">
    <title>Approach</title>
    <p>A flexible workflow for translational medicine big data needs to provide biomedical experts, such as medical doctors and life scientists, with a possibility to explore high-dimensional data sets. Given the complexity of source data, experts need to be able to flexibly define constraints and filters to focus on the most representative data points for particular health-related questions. Selected data points need to be processed, often in multiple analytical steps, as biomedical data are heterogeneous and represent complex readouts. Finally, biomedical experts need to interpret their findings in the context of biological mechanisms to formulate hypotheses on disease mechanisms.</p>
    <p>We decided to focus on translational medicine workflow providing the possibility of visually aided data exploration and informative hypothesis formulation. Therefore, our data integration platform of choice was tranSMART as it is a server-based solution with i2b2 data exploration component. We chose Galaxy as a workflow management system, considering its flexibility and the availability of tools. Finally, to provide informative interpretation of analytical results, we bridged the Galaxy Server with MINERVA platform, allowing overlay of exported data on disease-related mechanisms.</p>
    <p>We approached this problem in three steps:
<list list-type="simple"><list-item><p>1. Data integration and exploration are handled using tranSMART repository<sup><xref rid="B28" ref-type="bibr">28</xref></sup></p></list-item><list-item><p>2. Analysis of tranSMART-provided data is supported by Galaxy Server workflows<sup><xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B70" ref-type="bibr">70</xref>,<xref rid="B71" ref-type="bibr">71</xref></sup></p></list-item><list-item><p>3. Visualization of Galaxy-provided results is enabled via domain-specific knowledge repositories.<sup><xref rid="B58" ref-type="bibr">58</xref></sup></p></list-item></list></p>
    <p>The workflow, as illustrated in detail in <xref ref-type="fig" rid="f1">Figure 1</xref>, assumes a biomedical expert supervising each of the steps, while dedicated interfaces support automated data transition between each step.</p>
    <fig id="f1" fig-type="figure" orientation="portrait" position="float">
      <label>
        <bold>FIG. 1.</bold>
      </label>
      <caption>
        <p>A workflow for big data analytics in translational medicine. Clinical and “omics” data are integrated in the tranSMART database, allowing their exploration and selection of relevant subsets for downstream analysis. Selected data set is automatically transferred to Galaxy Server as a source for user-defined analytical pipelines. Finally, the results of the analysis are automatically transferred to an associated knowledge repository hosted on MINERVA platform (here: PD map) and displayed on the visualized molecular interaction networks. PD, Parkinson's disease.</p>
      </caption>
      <graphic xlink:href="fig-1"/>
    </fig>
    <sec id="s007">
      <title>Integration and exploration of clinical and molecular data in tranSMART database</title>
      <p>Translational medicine data sources are heterogeneous and of various granularities,<sup><xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B72" ref-type="bibr">72</xref></sup> and visually aided data exploration<sup><xref rid="B73" ref-type="bibr">73</xref></sup> is an important enabling technology for biomedical experts. The powerful visualization and interoperability functionalities of i2b2 are coupled together with omics integration in tranSMART<sup><xref rid="B28" ref-type="bibr">28</xref></sup> platform. tranSMART is a well-established platform enabling translation of preclinical research data into meaningful biological knowledge.<sup><xref rid="B74" ref-type="bibr">74</xref></sup> It supports integration of low-dimensional clinical data and high-dimensional molecular data in a data warehouse architecture. Although tranSMART by default relies on a relational database technology, it extends toward storing the high-dimensional biological data using NoSQL technology HBase.<sup><xref rid="B75" ref-type="bibr">75</xref></sup></p>
      <p>The platform features data interoperability connectors, including clinical information collection,<sup><xref rid="B76" ref-type="bibr">76</xref></sup> imaging data,<sup><xref rid="B77" ref-type="bibr">77</xref></sup> visual analytics,<sup><xref rid="B78" ref-type="bibr">78</xref></sup> or bioinformatics workflow management.<sup><xref rid="B79" ref-type="bibr">79</xref></sup> Finally, tranSMART features built-in data mining and analysis applications based on open-source systems, such as i2b2 and GenePattern,<sup><xref rid="B28" ref-type="bibr">28</xref></sup> and provides plugins to external tools, such as Dalliance Genome Browser,<sup><xref rid="B80" ref-type="bibr">80</xref></sup> or APIs for statistical packages, such as R.<sup><xref rid="B81" ref-type="bibr">81</xref></sup></p>
      <p>For the abovementioned reasons, tranSMART became a technology of choice for European Translational Information and Knowledge Management Services (eTRIKS, <uri xlink:type="simple" xlink:href="http://www.etriks.org">www.etriks.org</uri>) initiative. eTRIKS provides infrastructure for data staging, exploration, and use in translational research supported by Innovative Medicines Initiative (IMI). IMI is a collaborative scheme, in which academic institutions and pharmaceutical companies in Europe conduct large-scale biomedical research.</p>
      <p>To take advantage of the multiple functionalities of tranSMART, the target data sets have to be integrated following strict rules of data harmonization, semantic alignment, and quality checking. The data sets are curated following three common steps:
<list list-type="simple"><list-item><p>1. Data extraction: Source raw data files are extracted from either public or private data repositories. This could be a simple FTP transference from a Web repository or a database dump from a database management system, such as MySQL or Oracle™.</p></list-item><list-item><p>2. Data retrieval: Target information from the raw source files is identified and converted as Standard Format Files as defined by tranSMART curation guidelines. At this step, subject-level to sample-level data mapping is established.</p></list-item><list-item><p>3. Data annotation: Completing and standardizing annotations of metadata are also expected for guaranteeing data provenance.</p></list-item></list></p>
      <p>The final product of the abovementioned steps is a set of Standard Format Files, which are used as input by tranSMART's native ETL (Extract, Transform, and Load) scripts. After data curation and loading to tranSMART, features collected for subject and samples become variables of the corresponding data set. These variables, as well as the relationships among them, are represented as a hierarchical parent–child tree control structure (or simply “tree,” see <xref ref-type="fig" rid="f2">Fig. 2</xref>). This tree can be gradually expanded, which allows efficient data sets exploration and also the selection of variables from the hierarchy to build customized patient subsets for downstream analysis. Features that characterize desired data points in the tree, such as “age,” “gender,” or “disease state,” could be used as filters to narrow down the selected group. With tranSMART, researchers can pinpoint groups of patients and samples sharing similar characteristics, allowing straightforward hypothesis formulation. Easy identification of such coherent groups is a necessary prerequisite for accurate downstream analysis.</p>
      <fig id="f2" fig-type="figure" orientation="portrait" position="float">
        <label>
          <bold>FIG. 2.</bold>
        </label>
        <caption>
          <p>Cohort/subset definition based on the variables displayed in data tree. Two distinct subsets are defined based on the variables “disease state” and “gender.” In the left panel: data tree in tranSMART data set explorer. The data tree for GEO study GSE7621 following curation and loading to tranSMART is shown here. The data leafs correspond to the low- and high-dimensional data variable names. GEO, Gene Expression Omnibus.</p>
        </caption>
        <graphic xlink:href="fig-2"/>
      </fig>
      <p>tranSMART platform has certain limitations concerning the size of handled data sets. First, data curation and integration are very time-consuming steps, which are necessary to upload a multidimensional data collection to tranSMART. Only then, users benefit the most from visually aided data exploration and interpretation. Second, considering the growing volume of data collected per patient,<sup><xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B15" ref-type="bibr">15</xref></sup> data storage may become a bottleneck in the proposed architecture. In our experience with tranSMART, even when working with a data set of 15,000 patients each with 2000 clinical variables, the system was responsive (data not shown). However, storing omics for these patients in the native tranSMART database is an issue. NoSQL solutions can be considered to address the problem of both storage and analysis of large data.<sup><xref rid="B75" ref-type="bibr">75</xref></sup> Final bottleneck we foresee concerns the visualization capabilities of tranSMART. Displaying large amounts of data points via Web browsers is inefficient and may become a burden for large data sets.</p>
    </sec>
    <sec id="s008">
      <title>Analysis of selected data points using Galaxy Server</title>
      <p>The process of selection and filtering of tranSMART data results in a focused subset, which is suitable to answer a particular research question of a biomedical expert. For this to happen, an analytical workflow needs to be designed, pinpointing key characteristics of the selected subset.</p>
      <p>Galaxy as a bioinformatics workflow management system is available as both Web server and cloud workbench, offering flexibility in terms of data interoperability and allocation of computational resources.<sup><xref rid="B43" ref-type="bibr">43</xref>,<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B51" ref-type="bibr">51</xref></sup> The Galaxy environment automatically and transparently tracks every detail of the analysis, allows the construction of complex workflows, and permits the results to be documented, shared, and published with complete provenance, guaranteeing transparency and reproducibility.<sup><xref rid="B50" ref-type="bibr">50</xref></sup> Galaxy Tool Shed<sup><xref rid="B82" ref-type="bibr">82</xref></sup> is a repository of more than 3000 community-developed tools, allowing easy and versatile establishing of bioinformatics workflows.<sup><xref rid="B70" ref-type="bibr">70</xref>,<xref rid="B71" ref-type="bibr">71</xref></sup> Such workflows may combine different aspects of expert knowledge required in subsequent analytical steps. Basic knowledge about the system is sufficient to use default elements in the workflow construction. These default methods can be modified, where the user has sufficient expertise. Once the workflow step is done, users can easily share and modify it. Analytical results can be directly visualized using embedded functionalities or exported for downstream processing.</p>
      <p>Data interoperability and flexibility are important features of Galaxy. The platform is available in both server and cloud-based versions and bridges to the other major bioinformatics workflow management systems—Taverna,<sup><xref rid="B51" ref-type="bibr">51</xref></sup> KNIME, and gUSE.<sup><xref rid="B37" ref-type="bibr">37</xref></sup> Such architecture permits transparent and replicable design of analytical workflows for data exploration and formulation of data-driven hypotheses.</p>
      <p>Galaxy may face similar data volume-related issues as discussed above on tranSMART. In case of big omics data sets, data transfer and analysis may become time consuming, especially for large subsets chosen for analysis and complicated workflows. A possible solution to consider in such a case are advanced computational architectures offered by other workflow managers, such as gUSE. This solution is feasible to consider in the light of recent results on KNIME–Galaxy–gUSE workflow translation.<sup><xref rid="B37" ref-type="bibr">37</xref></sup></p>
    </sec>
    <sec id="s009">
      <title>Interpretation of analytical results using contextualized knowledge repositories</title>
      <p>High-dimensional translational medicine data sets are difficult material to draw conclusions relevant for human health. Data sets exported preselected from tranSMART database and analyzed using Galaxy will either, in many cases, remain multidimensional data sets or will be reduced to the list of prioritized molecules. Interpretation of such results remains challenging and requires both contextualization and visualization. Galaxy Server allows various export options. As the last step of our pipeline, we propose to interpret the results of analysis of Galaxy Server in the context of dedicated knowledge repositories supported by MINERVA platform, such as Parkinson's disease (PD) map.<sup><xref rid="B58" ref-type="bibr">58</xref>,<xref rid="B69" ref-type="bibr">69</xref></sup> In particular, molecules prioritized by the constructed pipeline are automatically visualized on molecular interaction networks hosted by MINERVA platform.<sup><xref rid="B69" ref-type="bibr">69</xref></sup></p>
      <p>Knowledge on detailed molecular mechanisms can be assembled in the context of a given biological mechanism or a particular perturbation of this mechanism—a disease. Among others, Systems Biology Graphical Notation (SBGN)<sup><xref rid="B83" ref-type="bibr">83</xref></sup> is used as a format for such mechanistic descriptions. Importantly, SBGN foresees a diagrammatical description of molecular mechanisms, introducing an important aspect of visualization to their curation. In effect, a “map” of molecular processes can be drawn and then visually explored for a comprehensive understanding of complex interactions. A number of systems biology-oriented maps were established following this paradigm.<sup><xref rid="B84" ref-type="bibr">84–86</xref></sup> More importantly, the so-called “disease maps” gained interest as a way to assemble an overview of pathways and perturbations specific to a given pathology.<sup><xref rid="B58" ref-type="bibr">58</xref>,<xref rid="B67" ref-type="bibr">67</xref>,<xref rid="B87" ref-type="bibr">87</xref>,<xref rid="B88" ref-type="bibr">88</xref></sup></p>
      <p>MINERVA platform is a Web server supporting curation and visualization of SBGN-compliant molecular interaction networks. The maps of biological processes can be drawn in editors supporting SBGN notation, such as CellDesigner (<uri xlink:type="simple" xlink:href="http://www.celldesigner.org">www.celldesigner.org</uri>) or SBGN-ED (<uri xlink:type="simple" xlink:href="http://www.sbgn-ed.org">www.sbgn-ed.org</uri>), and uploaded to an instance of MINERVA Web server. There, the maps are automatically verified and annotated and become accessible for exploration via Web browser. MINERVA features dedicated functionalities coupled with Google Maps API to enable intuitive visual exploration, interaction with visualized content, advanced search queries, and mapping experimental data on the displayed networks. In turn, drug-targeting interface facilitates health-related interpretation or hypothesis generation.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="s010">
    <title>Results</title>
    <p>We have combined three server-based platforms addressing different aspects of data processing in translational medicine research—data integration and exploration, bioinformatics workflow construction, and interpretation of analysis results in the disease context. In our choice of technologies, we focused on two criteria—capability for exploratory hypothesis generation and data interoperability. The platforms of our choice, tranSMART, Galaxy, and MINERVA, can be deployed as a single data processing workflow for translational medicine.</p>
    <p>We focused on available PD studies and exercised our workflow as described above, from data set selection and filtering in tranSMART, through analysis in Galaxy Server, to interpretation of results in the PD map—an open-access dedicated knowledge repository. We have established a dedicated Virtual Machine<xref ref-type="fn" rid="fn5">**</xref> to demonstrate the functioning of our workflow. To provide data sets for exploration, we have used tranSMART PD data sets we previously curated, which are also available at <uri xlink:type="simple" xlink:href="http://public.etriks.org">https://public.etriks.org</uri>.</p>
    <sec id="s011">
      <title>Integration and visual exploration of PD data sets in tranSMART</title>
      <p>For the first step of our workflow, we used PD-related studies that are publicly available in the Gene Expression Omnibus (GEO) database.<sup><xref rid="B89" ref-type="bibr">89</xref></sup> To integrate the GEO studies, data curation was performed to meet the required format of tranSMART,<sup><xref rid="B74" ref-type="bibr">74</xref></sup> as discussed above. In this use case, we worked with the GSE7621 PD study data<sup><xref rid="B90" ref-type="bibr">90</xref></sup> for defining two focused cohorts using tranSMART data set explorer.</p>
      <p>Study-related variables in tranSMART can be assigned to two broad categories: low- and high-dimensional data. Low-dimensional data correspond mostly to clinical, patient-centric data (e.g., systolic blood pressure) and low-throughput diagnostic measurements (e.g., quantification of a disease-related blood biomarker). The corresponding values of low-dimensional data are usually available as text or numeric values. High-dimensional data, in the majority reflecting “omics” data, are structured as a numeric matrix.</p>
      <p>For the purpose of this work, we used tranSMART for defining two specific patient cohorts based on low-dimensional data. We used tranSMART data set explorer to traverse the data tree displaying the low- and high-dimensional data variables for a given study (<xref ref-type="fig" rid="f2">Fig. 2</xref>). Using associated drag-and-drop functionality, we performed on-the-fly cohort definition. As can be seen in <xref ref-type="fig" rid="f2">Figure 2</xref>, the two cohorts have been defined based on the variables “disease state” and “gender.” Having these two cohorts, we were in subsequent steps to export their high-throughput data sets containing gene expression profiles of the patient brain samples for downstream analysis and visual exploration.</p>
    </sec>
    <sec id="s012">
      <title>Interface: tranSMART to Galaxy Server</title>
      <p>Once subcohorts are built using the i2b2 tree, all data related to the two subcohorts can be exported as tab-delimited files. This step is possible as tranSMART data interface enables export of all selected data to be shared with analytical tools. To make the gene expression data available to the Galaxy environment for further analysis, we used tranSMART data export functionality. This connection has been implemented within the collaboration of the eTRIKS consortium and the tranSMART foundation. In particular, exported data can be streamlined automatically to an associated Galaxy Server via the Galaxy plugin to tranSMART (<uri xlink:type="simple" xlink:href="http://github.com/thehyve/transmart-galaxy">https://github.com/thehyve/transmart-galaxy</uri>).</p>
      <p>The tranSMART–Galaxy interface uses the export function of tranSMART and transfers the files via Galaxy API to the Galaxy Server. User of Galaxy will then have access to the exported data of the subcohorts built in tranSMART. This way, preselected microarray data then become available in the Galaxy Server Workspace (GSW) for further analysis.</p>
      <p>Both tranSMART and Galaxy provide user access rights management functions. Here, we rely on security mechanisms natively provided by the two systems. The interface requires a preconfigured login–password pair to upload data to a dedicated GSW. The login–password pair is then used as a parameter in the interface configuration, such that only users having access rights to both systems can establish the interface and execute the data transfer over it.</p>
    </sec>
    <sec id="s013">
      <title>Analysis of a selected subset on Galaxy</title>
      <p>High-throughput data provided by tranSMART contain gene expression in samples from the two selected cohorts: males with PD (four samples) and age-matched healthy males (eight samples). The data files are automatically available in GSW after their export from tranSMART and can be used as input files.</p>
      <p>We have designed a dedicated Galaxy workflow (<xref ref-type="fig" rid="f3">Fig. 3</xref>). The workflow is subdivided into steps from incorporation of the input files taken from tranSMART through performing the differential expression analysis and uploading the obtained results to the PD map hosted on the MINERVA platform and making them accessible for interpretation in the disease-specific context.</p>
      <fig id="f3" fig-type="figure" orientation="portrait" position="float">
        <label>
          <bold>FIG. 3.</bold>
        </label>
        <caption>
          <p>Visually constructed data flow in the Galaxy Server comparing two cohorts from tranSMART.</p>
        </caption>
        <graphic xlink:href="fig-3"/>
      </fig>
      <p>A comparison between these two data sets provides insight about disease-related mechanisms that may be cohort specific. This differential gene expression was calculated as predefined method using Bioconductor package “limma” in Galaxy<sup><xref rid="B91" ref-type="bibr">91</xref>,<xref rid="B92" ref-type="bibr">92</xref></sup> (absolute fold change &gt;1.5, <italic>p</italic>-value &lt;0.05). The resulting list of 3286 differentially regulated genes was uploaded via MINERVA to the PD map for visual interpretation. This process led to the labeling of 224 different genes and/or their related protein products in the PD map.</p>
    </sec>
    <sec id="s014">
      <title>Interface: Galaxy Server to MINERVA</title>
      <p>MINERVA platform accepts POST requests, where the user specifies the target molecular network, user, password, and the data set to be uploaded. To ensure seamless data transfer from Galaxy to MINERVA, we created a step in the GSW called “PD map connector.”<sup><xref ref-type="fn" rid="fn6">††</xref></sup> This step generates a POST request to the associated MINERVA instance—PD map in this case—to generate a custom visualization on the basis of the workflow data.</p>
      <p>In the backend of the target MINERVA instance, a temporary session will be created for that particular data set to generate a custom layout, which will be available in the “Layouts” tab after user logs in. The uploaded data set may contain different types of elements, allowing coloring elements corresponding to multiple “omics” or interactions of the visualized network.<sup><xref rid="B69" ref-type="bibr">69</xref></sup></p>
      <p>By seamlessly connecting Galaxy Server to MINERVA platform, the users can securely transfer analysis results obtained from Galaxy workflows to MINERVA platform without leaving the Galaxy system. As shown below, visualization of the results on the PD map allows the identification of major molecular pathways perturbed in postmortem brain tissue of male Parkinson's patients, as selected in tranSMART and processed in Galaxy.</p>
    </sec>
    <sec id="s015">
      <title>Upload and interpretation of analysis results in the PD map</title>
      <p>The data exploration and analysis steps described above created a list of molecules characterizing the PD-related cohort in comparison to the controls. This list is then projected on the PD map, a contextualized knowledge repository of mechanisms relevant for the disease. The repository is hosted using the MINERVA platform, a Web service for visualization of molecular networks, with the capability of custom data upload and mapping.<sup><xref rid="B69" ref-type="bibr">69</xref></sup> Pathways and processes displayed in the PD map provide disease- and cellular context-related information.<sup><xref rid="B93" ref-type="bibr">93</xref></sup> More than 1500 molecular interactions displayed in the PD map are from more than 1000 PD-related publications manually curated by experts.<sup><xref rid="B58" ref-type="bibr">58</xref></sup></p>
      <p>Evaluation of highlighted areas in the PD map shows pronounced alterations in the cell nucleus, in particular a battery of downregulated (red) genes involved in metabolism and secretion of the neurotransmitter dopamine (<xref ref-type="fig" rid="f4">Fig. 4</xref>, blue circle<sup><xref ref-type="fn" rid="fn7">‡‡</xref></sup>).<sup><xref rid="B94" ref-type="bibr">94</xref></sup> Another visible perturbation affects the mitochondria, in particular elements of complex I (<xref ref-type="fig" rid="f4">Fig. 4</xref>, red circle<sup><xref ref-type="fn" rid="fn8">§§</xref></sup>). This process is essential for energy homeostasis, in particular in high energy demanding neurons. Finally, we observe upregulation (green) of processes involved in neuroinflammation (<xref ref-type="fig" rid="f4">Fig. 4</xref>, purple circle<xref ref-type="fn" rid="fn9">***</xref>).<sup><xref rid="B95" ref-type="bibr">95</xref></sup> On the basis of this visual exploration, data analyst may get comprehensive insights in molecular processes potentially involved in the disease of this specific patient cohort supporting new insights for diagnosis, prognosis, and therapy. Another approach for visualization is the drug target interface integrated in the MINERVA platform, enabling the mapping of potential drug interactions with elements of the map, suggesting more precise treatments and possibly an improvement in existing therapies.<sup><xref rid="B96" ref-type="bibr">96</xref></sup></p>
      <fig id="f4" fig-type="figure" orientation="portrait" position="float">
        <label>
          <bold>FIG. 4.</bold>
        </label>
        <caption>
          <p>Data visualization and analysis using PD map. <bold>(A)</bold> Differential gene expression data comparing postmortem brain tissues from male PD patients versus controls are displayed on the PD map (green, upregulated; red, downregulated). Pathways and processes of conspicuous areas (colored circle) could be identified using the pathway and compartment layout view of the PD map. Detailed view on deregulated genes that encode for proteins involved in dopamine metabolism, secretion, and recycling <bold>(B)</bold>, on mitochondrial electron transport chain, in particular elements of complex I <bold>(C)</bold>, and on microglia activation <bold>(D)</bold>.</p>
        </caption>
        <graphic xlink:href="fig-4"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="s016">
    <title>Conclusions</title>
    <p>Visualization is a necessary tool on the interface between the expert and big data processing pipelines. It is especially important in the field of translational medicine, where biomedical experts formulate and test their hypotheses about new diagnostic approaches or treatment. This process can be greatly supported with the available translational medicine big data, including clinical and molecular data sets.<sup><xref rid="B97" ref-type="bibr">97</xref></sup> Efforts in this direction are reflected with development of disease-oriented knowledge repositories, for example, for pulmonary<sup><xref rid="B26" ref-type="bibr">26</xref></sup> or neurodegenerative disorders.<sup><xref rid="B98" ref-type="bibr">98</xref></sup> Nevertheless, these knowledge bases lack seamless data flow and require a number of explicit data transformation steps for exploratory analysis. In turn, less technically versed users are restrained in data-driven hypothesis generation.</p>
    <p>Currently, a single person has to master a wide range of skills to perform a complete biomedical data analysis and interpretation. This is one of the reasons that big data integration, analytics, and interpretation become the true bottleneck of translational medicine.<sup><xref rid="B15" ref-type="bibr">15</xref></sup> We address this issue by seamlessly combining platforms supporting these steps, each of them having strong components of visually aided data exploration and analysis. Our approach is modular and capitalizes on strong points of each of the platforms, promoting data interoperability. Similar efforts have already been proposed,<sup><xref rid="B99" ref-type="bibr">99</xref></sup> involving tranSMART as data integration platform and a commercial solution GeneData as the analysis and interpretation engine. We believe that our pipeline extends their approach by involving a disease-related knowledge repository and by involving only open-access technologies will be useful for the scientific community.</p>
    <p>The platforms of our choice are server based, allowing construction of the entire pipeline in a protected environment, avoiding ethical and legal issues present in the cloud scenarios. Nevertheless, cloud computing paradigm is compelling, especially for researchers having limited storage and HPC capabilities.<sup><xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B16" ref-type="bibr">16</xref></sup> Efforts in this direction are promising<sup><xref rid="B31" ref-type="bibr">31</xref></sup> and need to be supported by further advances in data interoperability.<sup><xref rid="B12" ref-type="bibr">12</xref></sup> We believe our work is a step in this direction.</p>
  </sec>
</body>
<back>
  <sec id="s017" sec-type="ack">
    <title>Acknowledgments</title>
    <p>We would like to thank the reviewers of this article for their constructive remarks that helped in improving the article. We thank eTRIKS (<uri xlink:type="simple" xlink:href="http://www.etriks.org">www.etriks.org</uri>) and AETIONOMY (<uri xlink:type="simple" xlink:href="http://www.aetionomy.org">www.aetionomy.org</uri>) consortia. This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking AETIONOMY and eTRIKS grants and LCSB, University of Luxembourg.</p>
  </sec>
  <sec id="s018">
    <title>Author Contributions</title>
    <p>VS, WG, SE conceived and designed the project. ABS, WG, SE curated the data and integrated into tranSMART. VS, SE implemented Galaxy workflows. VS, PG developed the Galaxy-MINERVA interface. SG interpreted the experimental results. VS, RS, RB supervised the project. All the authors wrote and revised the manuscript, and MO coordinated the writing.</p>
  </sec>
  <sec id="s019">
    <title>Author Disclosure Statement</title>
    <p>No competing financial interests exist.</p>
  </sec>
  <ref-list content-type="parsed">
    <title>References</title>
    <ref id="B1">
      <label>1</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Topol</surname><given-names>EJ</given-names></name></person-group><article-title>The big medical data miss: Challenges in establishing an open medical resource</article-title>. <source>Nat Rev Genet</source>. <year>2015</year>;<volume>16</volume>:<fpage>253</fpage>–<lpage>254</lpage><pub-id pub-id-type="pmid">26065035</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bender</surname><given-names>E</given-names></name></person-group><article-title>Big data in biomedicine: 4 big questions</article-title>. <source>Nature</source>. <year>2015</year>;<volume>527</volume>:<fpage>S1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">26536215</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regan</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Payne</surname><given-names>PRO</given-names></name></person-group><article-title>From molecules to patients: The clinical applications of translational bioinformatics</article-title>. <source>Yearb Med Inform</source>. <year>2015</year>;<volume>10</volume>:<fpage>164</fpage>–<lpage>169</lpage><pub-id pub-id-type="pmid">26293863</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mardis</surname><given-names>ER</given-names></name></person-group><article-title>The $1,000 genome, the $100,000 analysis?</article-title><source>Genome Med</source>. <year>2010</year>;<volume>2</volume>:<fpage>8</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">20156317</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>FF</given-names></name></person-group><article-title>Big data in biomedicine</article-title>. <source>Drug Discov Today</source>. <year>2014</year>;<volume>19</volume>:<fpage>433</fpage>–<lpage>440</lpage><pub-id pub-id-type="pmid">24183925</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>VL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Borland</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hammond</surname><given-names>WE</given-names></name></person-group><article-title>Innovative information visualization of electronic health record data: A systematic review</article-title>. <source>J Am Med Informatics Assoc</source>. <year>2015</year>;<volume>22</volume>:<fpage>330</fpage>–<lpage>339</lpage></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bono</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Grenon</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sammut</surname><given-names>SJ</given-names></name></person-group><article-title>ApiNATOMY: A novel toolkit for visualizing multiscale anatomy schematics with phenotype-related information</article-title>. <source>Hum Mutat</source>. <year>2012</year>;<volume>33</volume>:<fpage>837</fpage>–<lpage>848</lpage><pub-id pub-id-type="pmid">22616108</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Q</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Price</surname><given-names>ND</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hood</surname><given-names>L</given-names></name></person-group><article-title>Systems cancer medicine: Towards realization of predictive, preventive, personalized and participatory (P4) medicine</article-title>. <source>J Intern Med</source>. <year>2012</year>;<volume>271</volume>:<fpage>111</fpage>–<lpage>121</lpage><pub-id pub-id-type="pmid">22142401</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yu</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name>, <etal>et al.</etal></person-group><article-title>Impaired long distance functional connectivity and weighted network architecture in Alzheimer's disease</article-title>. <source>Cereb Cortex</source>. <year>2014</year>;<volume>24</volume>:<fpage>1422</fpage>–<lpage>1435</lpage><pub-id pub-id-type="pmid">23314940</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butte</surname><given-names>AJ</given-names></name></person-group><article-title>Translational bioinformatics: Coming of age</article-title>. <source>J Am Med Inform Assoc</source>. <year>2008</year>;<volume>15</volume>:<fpage>709</fpage>–<lpage>714</lpage><pub-id pub-id-type="pmid">18755990</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreu-Perez</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Poon</surname><given-names>CCY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Merrifield</surname><given-names>RD</given-names></name>, <etal>et al.</etal></person-group><article-title>Big Data for health</article-title>. <source>IEEE J Biomed Heal Inform</source>. <year>2015</year>;<volume>19</volume>:<fpage>1193</fpage>–<lpage>1208</lpage></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wade</surname><given-names>TD</given-names></name></person-group><article-title>Traits and types of health data repositories</article-title>. <source>Health Inf Sci Syst</source>. <year>2014</year>;<volume>2</volume>:<fpage>4</fpage><pub-id pub-id-type="pmid">25825668</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merelli</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pérez-Sánchez</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gesing</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>D'Agostino</surname><given-names>D</given-names></name></person-group><article-title>Managing, analysing, and integrating big data in medical bioinformatics: Open problems and future perspectives</article-title>. <source>Biomed Res Int</source>. <year>2014</year>;<volume>2014</volume>:<fpage>1</fpage>–<lpage>13</lpage></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14</label>
      <mixed-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Stonebraker</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Beskales</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pagan</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group><article-title>Data curation at scale: The Data Tamer System</article-title>. In: <conf-name>Proceedings of the 6th Biennial Conference on Innovative Data Systems Research</conf-name><conf-loc>Asilomar, CA</conf-loc>, <conf-date><month>1</month><day>6–9</day>, <year>2013</year></conf-date></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alyass</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Turcotte</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Meyre</surname><given-names>D</given-names></name></person-group><article-title>From big data analysis to personalized medicine for all: Challenges and opportunities</article-title>. <source>BMC Med Genomics</source>. <year>2015</year>;<volume>8</volume>:<fpage>3</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">25888889</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wu</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gopukumar</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name></person-group><article-title>Big data application in biomedical research and health care: A literature review</article-title>. <source>Biomed Inform Insights</source>. <year>2016</year>;<volume>8</volume>:<fpage>1</fpage>–<lpage>10</lpage><pub-id pub-id-type="pmid">26843812</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dove</surname><given-names>ES</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Joly</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tassé</surname><given-names>A-M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Knoppers</surname><given-names>BM</given-names></name></person-group><article-title>Genomic cloud computing: Legal and ethical points to consider</article-title>. <source>Eur J Hum Genet</source>. <year>2015</year>;<volume>23</volume>:<fpage>1271</fpage>–<lpage>1278</lpage><pub-id pub-id-type="pmid">25248396</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canuel</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rance</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Avillach</surname><given-names>P</given-names></name>, <etal>et al.</etal></person-group><article-title>Translational research platforms integrating clinical and omics data: A review of publicly available solutions</article-title>. <source>Brief Bioinform</source>. <year>2015</year>;<volume>16</volume>:<fpage>280</fpage>–<lpage>290</lpage><pub-id pub-id-type="pmid">24608524</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>HJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ferris</surname><given-names>TA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>PM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Weber</surname><given-names>SC</given-names></name></person-group><article-title>STRIDE—An integrated standards-based translational research informatics platform</article-title>. <source>AMIA Annu Symp Proc</source>. <year>2009</year>;<volume>2009</volume>:<fpage>391</fpage>–<lpage>395</lpage><pub-id pub-id-type="pmid">20351886</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno-Machado</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bafna</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boxwala</surname><given-names>AA</given-names></name>, <etal>et al.</etal></person-group><article-title>iDASH: Integrating data for analysis, anonymization, and sharing</article-title>. <source>J Am Med Inform Assoc</source>. <year>2012</year>;<volume>19</volume>:<fpage>196</fpage>–<lpage>201</lpage><pub-id pub-id-type="pmid">22081224</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oster</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Langella</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hastings</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group><article-title>caGrid 1.0: An Enterprise Grid Infrastructure for Biomedical Research</article-title>. <source>J Am Med Inform Assoc</source>. <year>2008</year>;<volume>15</volume>:<fpage>138</fpage>–<lpage>149</lpage><pub-id pub-id-type="pmid">18096909</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ervin</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dhaval</surname><given-names>R</given-names></name>, <etal>et al.</etal></person-group><article-title>TRIAD: The Translational Research Informatics and Data Management Grid</article-title>. <source>Appl Clin Inform</source>. <year>2011</year>;<volume>2</volume>:<fpage>331</fpage>–<lpage>344</lpage><pub-id pub-id-type="pmid">23616879</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toga</surname><given-names>AW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Foster</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kesselman</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group><article-title>Big Biomedical data as the key resource for discovery science</article-title>. <source>J Am Med Inform Assoc</source>. <year>2015</year>;<volume>22</volume>:<fpage>1126</fpage>–<lpage>1131</lpage><pub-id pub-id-type="pmid">26198305</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerami</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gao</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dogrusoz</surname><given-names>U</given-names></name>, <etal>et al.</etal></person-group><article-title>The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data</article-title>. <source>Cancer Discov</source>. <year>2012</year>;<volume>2</volume>:<fpage>401</fpage>–<lpage>404</lpage><pub-id pub-id-type="pmid">22588877</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madhavan</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gauba</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Song</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group><article-title>Platform for personalized oncology: Integrative analyses reveal novel molecular signatures associated with colorectal cancer relapse</article-title>. <source>AMIA Jt Summits Transl Sci Proc</source>. <year>2013</year>;<volume>2013</volume>:<fpage>11</fpage><lpage>8</lpage></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cano</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tényi</surname><given-names>Á</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schueller</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group><article-title>The COPD Knowledge Base: Enabling data analysis and computational simulation in translational COPD research</article-title>. <source>J Transl Med</source>. <year>2014</year>;<volume>12</volume>:<fpage>S6</fpage><pub-id pub-id-type="pmid">25471253</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tripp</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Daley</surname><given-names>D</given-names></name></person-group><article-title>BRISK—research-oriented storage kit for biology-related data</article-title>. <source>Bioinformatics</source>. <year>2011</year>;<volume>27</volume>:<fpage>2422</fpage>–<lpage>2425</lpage><pub-id pub-id-type="pmid">21712248</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szalma</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Koka</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Khasanova</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perakslis</surname><given-names>ED</given-names></name></person-group><article-title>Effective knowledge management in translational medicine</article-title>. <source>J Transl Med</source>. <year>2010</year>;<volume>8</volume>:<fpage>6</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">20105294</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saulnier Sholler</surname><given-names>GL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bergendahl</surname><given-names>G</given-names></name>, <etal>et al.</etal></person-group><article-title>A pilot trial testing the feasibility of using molecular-guided therapy in patients with recurrent neuroblastoma</article-title>. <source>J Cancer Ther</source>. <year>2012</year>;<volume>3</volume>:<fpage>602</fpage>–<lpage>612</lpage></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natter</surname><given-names>MD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Quan</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ortiz</surname><given-names>DM</given-names></name>, <etal>et al.</etal></person-group><article-title>An i2b2-based, generalizable, open source, self-scaling chronic disease registry</article-title>. <source>J Am Med Inform Assoc</source>. <year>2013</year>;<volume>20</volume>:<fpage>172</fpage>–<lpage>179</lpage><pub-id pub-id-type="pmid">22733975</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>TD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Raniga</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barnes</surname><given-names>DG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Egan</surname><given-names>GF</given-names></name></person-group><article-title>Design, implementation and operation of a multimodality research imaging informatics repository</article-title>. <source>Health Inf Sci Syst</source>. <year>2015</year>;<volume>3</volume>:<fpage>S6</fpage><pub-id pub-id-type="pmid">25870760</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Churchill</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bry</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group><article-title>Instrumenting the health care enterprise for discovery research in the genomic era</article-title>. <source>Genome Res</source>. <year>2009</year>;<volume>19</volume>:<fpage>1675</fpage>–<lpage>1681</lpage><pub-id pub-id-type="pmid">19602638</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>SN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Weber</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mendis</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group><article-title>Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2)</article-title>. <source>J Am Med Inform Assoc</source>. <year>2010</year>;<volume>17</volume>:<fpage>124</fpage>–<lpage>130</lpage><pub-id pub-id-type="pmid">20190053</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gainer</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hackett</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mendis</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group><article-title>Using the i2b2 hive for clinical discovery: An example</article-title>. <source>AMIA Annu Symp Proc</source>. <year>2007</year>;<fpage>959</fpage><pub-id pub-id-type="pmid">18694059</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalaitzopoulos</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Patel</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Younesi</surname><given-names>E</given-names></name></person-group><article-title>Advancements in Data Management and Data Mining Approaches</article-title>. <source>Transl Med</source>. <year>2016</year>;<volume>31</volume>:<fpage>35</fpage>–<lpage>53</lpage></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leipzig</surname><given-names>J.</given-names></name></person-group><article-title>A review of bioinformatic pipeline frameworks</article-title>. <source>Brief Bioinform</source>. [Epub ahead of print]; DOI: <pub-id pub-id-type="doi">10.1093/bib/bbw020</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Garza</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Veit</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Szolek</surname><given-names>A</given-names></name>, <etal>et al.</etal></person-group><article-title>From the desktop to the grid: Scalable bioinformatics via workflow conversion</article-title>. <source>BMC Bioinformatics</source>. <year>2016</year>;<volume>17</volume>:<fpage>12</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">26823190</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afgan</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sloggett</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Goonasekera</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group><article-title>Genomics virtual laboratory: A practical bioinformatics workbench for the cloud</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>:<fpage>e014082</fpage><lpage>9</lpage></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köster</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rahmann</surname><given-names>S</given-names></name></person-group><article-title>Snakemake—a scalable bioinformatics workflow engine</article-title>. <source>Bioinformatics</source>. <year>2012</year>;<volume>28</volume>:<fpage>2520</fpage>–<lpage>2522</lpage><pub-id pub-id-type="pmid">22908215</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>AA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Macgregor</surname><given-names>AB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Szabo</surname><given-names>TO</given-names></name>, <etal>et al.</etal></person-group><article-title>Yabi: An online research environment for grid, high performance and cloud computing</article-title>. <source>Source Code Biol Med</source>. <year>2012</year>;<volume>7</volume>:<fpage>1</fpage><pub-id pub-id-type="pmid">22333270</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallio</surname><given-names>MA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tuimala</surname><given-names>JT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hupponen</surname><given-names>T</given-names></name>, <etal>et al.</etal></person-group><article-title>Chipster: User-friendly analysis software for microarray and other high-throughput data</article-title>. <source>BMC Genomics</source>. <year>2011</year>;<volume>12</volume>:<fpage>50</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21251254</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neron</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Menager</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Maufrais</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group><article-title>Mobyle: A new full web bioinformatics framework</article-title>. <source>Bioinformatics</source>. <year>2009</year>;<volume>25</volume>:<fpage>3005</fpage>–<lpage>3011</lpage><pub-id pub-id-type="pmid">19689959</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goecks</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nekrutenko</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Taylor</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Galaxy Team</surname><given-names>T</given-names></name></person-group><article-title>Galaxy: A comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences</article-title>. <source>Genome Biol</source>. <year>2010</year>;<volume>11</volume>:<fpage>R8</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">20096101</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolstencroft</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Haines</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fellows</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group><article-title>The Taverna workflow suite: Designing and executing workflows of Web Services on the desktop, web or in the cloud</article-title>. <source>Nucleic Acids Res</source>. <year>2013</year>;<volume>41</volume>:<fpage>W557</fpage>–<lpage>W561</lpage><pub-id pub-id-type="pmid">23640334</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warr</surname><given-names>WA</given-names></name></person-group><article-title>Scientific workflow systems: Pipeline Pilot and KNIME</article-title>. <source>J Comput Aided Mol Des</source>. <year>2012</year>;<volume>26</volume>:<fpage>801</fpage>–<lpage>804</lpage><pub-id pub-id-type="pmid">22644661</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <label>46</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jagla</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wiswedel</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Coppee</surname><given-names>J-Y</given-names></name></person-group><article-title>Extending KNIME for next-generation sequencing data analysis</article-title>. <source>Bioinformatics</source>. <year>2011</year>;<volume>27</volume>:<fpage>2907</fpage>–<lpage>2909</lpage><pub-id pub-id-type="pmid">21873641</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kacsuk</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Farkas</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kozlovszky</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group><article-title>WS-PGRADE/gUSE generic DCI gateway framework for a large variety of user communities</article-title>. <source>J Grid Comput</source>. <year>2012</year>;<volume>10</volume>:<fpage>601</fpage>–<lpage>630</lpage></mixed-citation>
    </ref>
    <ref id="B48">
      <label>48</label>
      <mixed-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Dooley</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vaughn</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stanzione</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group><article-title>Software-as-a-Service: The iPlant Foundation API</article-title>. In:<conf-name>5th IEEE Workshop on Many-Task Computing Grids and Supercomputers (MTAGS)</conf-name><publisher-name>IEEE</publisher-name>, <year>2012</year></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49</label>
      <mixed-citation publication-type="web"><collab>Arvados.</collab><article-title>A free and open source platform for big data science</article-title>. <year>2013</year> Available online at <uri xlink:type="simple" xlink:href="http://doc.arvados.org">http://doc.arvados.org</uri> (last accessed <date-in-citation><month>4</month><day>25</day>, <year>2016</year></date-in-citation>)</mixed-citation>
    </ref>
    <ref id="B50">
      <label>50</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afgan</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Baker</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Coraor</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group><article-title>Harnessing cloud computing with Galaxy Cloud</article-title>. <source>Nat Biotechnol</source>. <year>2011</year>;<volume>29</volume>:<fpage>972</fpage>–<lpage>974</lpage><pub-id pub-id-type="pmid">22068528</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <label>51</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abouelhoda</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Issa</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ghanem</surname><given-names>M</given-names></name></person-group><article-title>Tavaxy: Integrating Taverna and Galaxy workflows with cloud computing support</article-title>. <source>BMC Bioinformatics</source>. <year>2012</year>;<volume>13</volume>:<fpage>7</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22233443</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <label>52</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacunski</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tatonetti</surname><given-names>NP</given-names></name></person-group><article-title>Connecting the dots: Applications of network medicine in pharmacology and disease</article-title>. <source>Clin Pharmacol Ther</source>. <year>2013</year>;<volume>94</volume>:<fpage>659</fpage>–<lpage>669</lpage><pub-id pub-id-type="pmid">23995266</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <label>53</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerasch</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Faber</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Küntzer</surname><given-names>J</given-names></name>, <etal>et al.</etal></person-group><article-title>BiNA: A visual analytics tool for biological network data</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>:<fpage>e8739</fpage><lpage>7</lpage></mixed-citation>
    </ref>
    <ref id="B54">
      <label>54</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzuti</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rombo</surname><given-names>SE</given-names></name></person-group><article-title>Algorithms and tools for protein-protein interaction networks clustering, with a special focus on population-based stochastic methods</article-title>. <source>Bioinformatics</source>. <year>2014</year>;<volume>30</volume>:<fpage>1343</fpage>–<lpage>1352</lpage><pub-id pub-id-type="pmid">24458952</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <label>55</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>T-M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Park</surname><given-names>PJ</given-names></name></person-group><article-title>Advances in analysis of transcriptional regulatory networks</article-title>. <source>Wiley Interdiscip Rev Syst Biol Med</source>. <year>2011</year>;<volume>3</volume>:<fpage>21</fpage>–<lpage>35</lpage><pub-id pub-id-type="pmid">21069662</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <label>56</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wan</surname><given-names>Y-W</given-names></name></person-group><article-title>Network-based identification of biomarkers coexpressed with multiple pathways</article-title>. <source>Cancer Inform</source>. <year>2014</year>;<volume>13</volume>(<issue>Suppl 5</issue>):<fpage>37</fpage>–<lpage>47</lpage><pub-id pub-id-type="pmid">25392692</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <label>57</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Leser</surname><given-names>U</given-names></name></person-group><article-title>A survey on annotation tools for the biomedical literature</article-title>. <source>Brief Bioinform</source>. <year>2014</year>;<volume>15</volume>:<fpage>327</fpage>–<lpage>340</lpage><pub-id pub-id-type="pmid">23255168</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <label>58</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>KA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ostaszewski</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>Y</given-names></name>, <etal>et al.</etal></person-group><article-title>Integrating pathways of Parkinson's disease in a molecular interaction map</article-title>. <source>Mol Neurobiol</source>. <year>2014</year>;<volume>49</volume>:<fpage>88</fpage>–<lpage>102</lpage><pub-id pub-id-type="pmid">23832570</pub-id></mixed-citation>
    </ref>
    <ref id="B59">
      <label>59</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutmon</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Riutta</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nunes</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group><article-title>WikiPathways: Capturing the full diversity of pathway knowledge</article-title>. <source>Nucleic Acids Res</source>. <year>2016</year>;<volume>44</volume>:<fpage>D488</fpage>–<lpage>D494</lpage><pub-id pub-id-type="pmid">26481357</pub-id></mixed-citation>
    </ref>
    <ref id="B60">
      <label>60</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glaab</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schneider</surname><given-names>R</given-names></name></person-group><article-title>PathVar: Analysis of gene and protein expression variance in cellular pathways using microarray data</article-title>. <source>Bioinformatics</source>. <year>2012</year>;<volume>28</volume>:<fpage>446</fpage>–<lpage>447</lpage><pub-id pub-id-type="pmid">22123829</pub-id></mixed-citation>
    </ref>
    <ref id="B61">
      <label>61</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Green</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pollard</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tugendreich</surname><given-names>S</given-names></name></person-group><article-title>Causal analysis approaches in Ingenuity Pathway Analysis</article-title>. <source>Bioinformatics</source>. <year>2014</year>;<volume>30</volume>:<fpage>523</fpage>–<lpage>530</lpage><pub-id pub-id-type="pmid">24336805</pub-id></mixed-citation>
    </ref>
    <ref id="B62">
      <label>62</label>
      <mixed-citation publication-type="web"><collab>Pathway Studio<sup>®</sup>.</collab><article-title>Experimental data and disease models at the heart of biological research</article-title>. <year>2016</year> Available online at <uri xlink:type="simple" xlink:href="http://www.elsevier.com/solutions/pathway-studio-biological-research">www.elsevier.com/solutions/pathway-studio-biological-research</uri> (last accessed <date-in-citation><month>4</month><day>25</day>, <year>2016</year></date-in-citation>)</mixed-citation>
    </ref>
    <ref id="B63">
      <label>63</label>
      <mixed-citation publication-type="web"><collab>MetaCore. MetaCore and Key Pathway Advisor Data-mining and pathway analysis</collab>. <year>2016</year> Available online at <uri xlink:type="simple" xlink:href="http://ipscience.thomsonreuters.com/product/metacore">http://ipscience.thomsonreuters.com/product/metacore</uri> (last accessed on <date-in-citation><month>4</month><day>25</day>, <year>2016</year></date-in-citation>)</mixed-citation>
    </ref>
    <ref id="B64">
      <label>64</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Goto</surname><given-names>S</given-names></name></person-group><article-title>KEGG: Kyoto encyclopedia of genes and genomes</article-title>. <source>Nucleic Acids Res</source>. <year>2000</year>;<volume>28</volume>:<fpage>27</fpage>–<lpage>30</lpage><pub-id pub-id-type="pmid">10592173</pub-id></mixed-citation>
    </ref>
    <ref id="B65">
      <label>65</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croft</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mundo</surname><given-names>AF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Haw</surname><given-names>R</given-names></name>, <etal>et al.</etal></person-group><article-title>The Reactome pathway knowledgebase</article-title>. <source>Nucleic Acids Res</source>. <year>2014</year>;<volume>42</volume>:<fpage>D472</fpage>–<lpage>D477</lpage><pub-id pub-id-type="pmid">24243840</pub-id></mixed-citation>
    </ref>
    <ref id="B66">
      <label>66</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Iijima</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ogishima</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group><article-title>AlzPathway: A comprehensive map of signaling pathways of Alzheimer's disease</article-title>. <source>BMC Syst Biol</source>. <year>2012</year>;<volume>6</volume>:<fpage>5</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">22257493</pub-id></mixed-citation>
    </ref>
    <ref id="B67">
      <label>67</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuperstein</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bonnet</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>H-A</given-names></name>, <etal>et al.</etal></person-group><article-title>Atlas of cancer signalling network: A systems biology resource for integrative analysis of cancer data with Google Maps</article-title>. <source>Oncogenesis</source>. <year>2015</year>;<volume>4</volume>:<fpage>e16</fpage><lpage>0</lpage></mixed-citation>
    </ref>
    <ref id="B68">
      <label>68</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnet</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Viara</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kuperstein</surname><given-names>I</given-names></name>, <etal>et al.</etal></person-group><article-title>NaviCell Web Service for network-based data visualization</article-title>. <source>Nucleic Acids Res</source>. <year>2015</year>;<volume>43</volume>:<fpage>W560</fpage>–<lpage>W565</lpage><pub-id pub-id-type="pmid">25958393</pub-id></mixed-citation>
    </ref>
    <ref id="B69">
      <label>69</label>
      <mixed-citation publication-type="web"><person-group person-group-type="author"><name><surname>Gawron</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ostaszewski</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Satagopam</surname><given-names>V</given-names></name>, <etal>et al.</etal></person-group><article-title>MINERVA—a platform for visualization and curation of molecular interaction networks</article-title>. <year>2016</year> Available online at <uri xlink:type="simple" xlink:href="http://r3lab.uni.lu/web/minerva-website">http://r3lab.uni.lu/web/minerva-website</uri> (last accessed <date-in-citation><month>4</month><day>25</day>, <year>2016</year></date-in-citation>)</mixed-citation>
    </ref>
    <ref id="B70">
      <label>70</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blankenberg</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Von Kuster</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Coraor</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group><article-title>Galaxy: A web-based genome analysis tool for experimentalists</article-title>. <source>Curr Protoc Mol Biol</source>. <year>2010</year>;Chapter 19:<fpage>19</fpage><comment>.10.1–21.</comment><pub-id pub-id-type="pmid">20583098</pub-id></mixed-citation>
    </ref>
    <ref id="B71">
      <label>71</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giardine</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Riemer</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hardison</surname><given-names>RC</given-names></name>, <etal>et al.</etal></person-group><article-title>Galaxy: A platform for interactive large-scale genome analysis</article-title>. <source>Genome Res</source>. <year>2005</year>;<volume>15</volume>:<fpage>1451</fpage>–<lpage>1455</lpage><pub-id pub-id-type="pmid">16169926</pub-id></mixed-citation>
    </ref>
    <ref id="B72">
      <label>72</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Sanchez</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Verspoor</surname><given-names>K</given-names></name></person-group><article-title>Big data in medicine is driving big changes</article-title>. <source>Yearb Med Inform</source>. <year>2014</year>;<volume>9</volume>:<fpage>14</fpage>–<lpage>20</lpage><pub-id pub-id-type="pmid">25123716</pub-id></mixed-citation>
    </ref>
    <ref id="B73">
      <label>73</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shneiderman</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Plaisant</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hesse</surname><given-names>BW</given-names></name></person-group><article-title>Improving healthcare with interactive visualization</article-title>. <source>Computer</source>. <year>2013</year>;<volume>46</volume>:<fpage>58</fpage>–<lpage>66</lpage></mixed-citation>
    </ref>
    <ref id="B74">
      <label>74</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheufele</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Aronzon</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Coopersmith</surname><given-names>R</given-names></name>, <etal>et al.</etal></person-group><article-title>tranSMART: An Open Source Knowledge Management and High Content Data Analytics Platform</article-title>. <source>AMIA Jt Summits Transl Sci Proc</source>. <year>2014</year>;<volume>2014</volume>:<fpage>96</fpage>–<lpage>101</lpage><pub-id pub-id-type="pmid">25717408</pub-id></mixed-citation>
    </ref>
    <ref id="B75">
      <label>75</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pandis</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wu</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group><article-title>High dimensional biological data retrieval optimization with NoSQL technology</article-title>. <source>BMC Genomics</source>. <year>2014</year>;<volume>15</volume>:<fpage>S3</fpage></mixed-citation>
    </ref>
    <ref id="B76">
      <label>76</label>
      <mixed-citation publication-type="web"><person-group person-group-type="author"><name><surname>Blondé</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>de Bruijn</surname><given-names>F</given-names></name></person-group><article-title>OpenClinica and RedCap conversion to transMART</article-title>. <year>2015</year> Available online at <uri xlink:type="simple" xlink:href="http://github.com/CTMM-TraIT/trait_odm_to_i2b2">https://github.com/CTMM-TraIT/trait_odm_to_i2b2</uri> (last accessed <date-in-citation><month>4</month><day>25</day>, <year>2016</year></date-in-citation>)</mixed-citation>
    </ref>
    <ref id="B77">
      <label>77</label>
      <mixed-citation publication-type="web"><person-group person-group-type="author"><name><surname>Vast</surname><given-names>E</given-names></name></person-group><article-title>tranSMART XNAT importer</article-title>. <year>2015</year> Available online at <uri xlink:type="simple" xlink:href="http://github.com/evast/transmart-xnat-importer-plugin">https://github.com/evast/transmart-xnat-importer-plugin</uri> (last accessed <date-in-citation><month>4</month><day>25</day>, <year>2016</year></date-in-citation>)</mixed-citation>
    </ref>
    <ref id="B78">
      <label>78</label>
      <mixed-citation publication-type="web"><person-group person-group-type="author"><name><surname>Herzinger</surname><given-names>S.</given-names></name></person-group><article-title>SmartR: A grails plugin for visual analytics of the tranSMART platform using recent web technologies</article-title>. Available online at <uri xlink:type="simple" xlink:href="http://github.com/transmart/SmartR">https://github.com/transmart/SmartR</uri> (last accessed on <date-in-citation><month>4</month><day>25</day>, <year>2016</year></date-in-citation>)</mixed-citation>
    </ref>
    <ref id="B79">
      <label>79</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bierkens</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>van der Linden</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>van Bochove</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group><article-title>tranSMART</article-title>. <source>J Clin Bioinforma</source>. <year>2015</year>;<volume>5</volume>:<fpage>S9</fpage></mixed-citation>
    </ref>
    <ref id="B80">
      <label>80</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Down</surname><given-names>TA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Piipari</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hubbard</surname><given-names>TJP</given-names></name></person-group><article-title>Dalliance: Interactive genome viewing on the web</article-title>. <source>Bioinformatics</source>. <year>2011</year>;<volume>27</volume>:<fpage>889</fpage>–<lpage>890</lpage><pub-id pub-id-type="pmid">21252075</pub-id></mixed-citation>
    </ref>
    <ref id="B81">
      <label>81</label>
      <mixed-citation publication-type="book"><collab>R Core Team</collab>. <article-title>R: A Language and Environment for Statistical Computing</article-title>. <publisher-loc>Vienna, Austria</publisher-loc>, <year>2013</year></mixed-citation>
    </ref>
    <ref id="B82">
      <label>82</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazarus</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kaspi</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ziemann</surname><given-names>M</given-names></name></person-group><article-title>Creating reusable tools from scripts: The Galaxy Tool Factory</article-title>. <source>Bioinformatics</source>. <year>2012</year>;<volume>28</volume>:<fpage>3139</fpage>–<lpage>3140</lpage><pub-id pub-id-type="pmid">23024011</pub-id></mixed-citation>
    </ref>
    <ref id="B83">
      <label>83</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Novère</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hucka</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mi</surname><given-names>H</given-names></name>, <etal>et al.</etal></person-group><article-title>The systems biology graphical notation</article-title>. <source>Nat Biotechnol</source>. <year>2009</year>;<volume>27</volume>:<fpage>735</fpage>–<lpage>741</lpage><pub-id pub-id-type="pmid">19668183</pub-id></mixed-citation>
    </ref>
    <ref id="B84">
      <label>84</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oda</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Funahashi</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kitano</surname><given-names>H</given-names></name></person-group><article-title>A comprehensive pathway map of epidermal growth factor receptor signaling</article-title>. <source>Mol Syst Biol</source>. <year>2005</year>;<volume>1</volume>:<fpage>200</fpage><lpage>5</lpage><comment>.0010.</comment></mixed-citation>
    </ref>
    <ref id="B85">
      <label>85</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oda</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kitano</surname><given-names>H</given-names></name></person-group><article-title>A comprehensive map of the toll-like receptor signaling network</article-title>. <source>Mol Syst Biol</source>. <year>2006</year>;<volume>2</volume>:<fpage>200</fpage><lpage>6</lpage><comment>.0015.</comment></mixed-citation>
    </ref>
    <ref id="B86">
      <label>86</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caron</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>Y</given-names></name>, <etal>et al.</etal></person-group><article-title>A comprehensive map of the mTOR signaling network</article-title>. <source>Mol Syst Biol</source>. <year>2010</year>;<volume>6</volume>:<fpage>45</fpage><lpage>3</lpage></mixed-citation>
    </ref>
    <ref id="B87">
      <label>87</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Matsumae</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Katoh</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group><article-title>A comprehensive map of the influenza A virus replication cycle</article-title>. <source>BMC Syst Biol</source>. <year>2013</year>;<volume>7</volume>:<fpage>9</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">23339444</pub-id></mixed-citation>
    </ref>
    <ref id="B88">
      <label>88</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Iijima</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ogishima</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group><article-title>AlzPathway: A comprehensive map of signaling pathways of Alzheimer's disease</article-title>. <source>BMC Syst Biol</source>. <year>2012</year>;<volume>6</volume>:<fpage>5</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">22257493</pub-id></mixed-citation>
    </ref>
    <ref id="B89">
      <label>89</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wilhite</surname><given-names>SE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ledoux</surname><given-names>P</given-names></name>, <etal>et al.</etal></person-group><article-title>NCBI GEO: Archive for functional genomics data sets—update</article-title>. <source>Nucleic Acids Res</source>. <year>2013</year>;<volume>41</volume>:<fpage>D991</fpage>–<lpage>D995</lpage><pub-id pub-id-type="pmid">23193258</pub-id></mixed-citation>
    </ref>
    <ref id="B90">
      <label>90</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesnick</surname><given-names>TG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Papapetropoulos</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mash</surname><given-names>DC</given-names></name>, <etal>et al.</etal></person-group><article-title>A genomic pathway approach to a complex disease: Axon guidance and Parkinson disease</article-title>. <source>PLoS Genet</source>. <year>2007</year>;<volume>3</volume>:<fpage>e9</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17222061</pub-id></mixed-citation>
    </ref>
    <ref id="B91">
      <label>91</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>Limma: Linear models for microarray data</article-title>. In: <person-group person-group-type="editor"><name><surname>Gentleman</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Carey</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Huber</surname><given-names>W</given-names></name>, <etal>et al.</etal></person-group> (Eds.): Bioinformatics and Computational Biology Solutions Using R and Bioconductor. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>, <year>2005</year>, pp. <fpage>397</fpage>–<lpage>420</lpage></mixed-citation>
    </ref>
    <ref id="B92">
      <label>92</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>ME</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Phipson</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wu</surname><given-names>D</given-names></name>, <etal>et al.</etal></person-group><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res</source>. <year>2015</year>;<volume>43</volume>:<fpage>e4</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">25378315</pub-id></mixed-citation>
    </ref>
    <ref id="B93">
      <label>93</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann-Apitius</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ball</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gebel</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group><article-title>Bioinformatics mining and modeling methods for the identification of disease mechanisms in neurodegenerative disorders</article-title>. <source>Int J Mol Sci</source>. <year>2015</year>;<volume>16</volume>:<fpage>29179</fpage>–<lpage>29206</lpage><pub-id pub-id-type="pmid">26690135</pub-id></mixed-citation>
    </ref>
    <ref id="B94">
      <label>94</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meiser</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Weindl</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hiller</surname><given-names>K</given-names></name></person-group><article-title>Complexity of dopamine metabolism</article-title>. <source>Cell Commun Signal</source>. <year>2013</year>;<volume>11</volume>:<fpage>3</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">23311350</pub-id></mixed-citation>
    </ref>
    <ref id="B95">
      <label>95</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glass</surname><given-names>CK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Saijo</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Winner</surname><given-names>B</given-names></name>, <etal>et al.</etal></person-group><article-title>Mechanisms underlying inflammation in neurodegeneration</article-title>. <source>Cell</source>. <year>2010</year>;<volume>140</volume>:<fpage>918</fpage>–<lpage>934</lpage><pub-id pub-id-type="pmid">20303880</pub-id></mixed-citation>
    </ref>
    <ref id="B96">
      <label>96</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poletti</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bonuccelli</surname><given-names>U</given-names></name></person-group><article-title>Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: A review</article-title>. <source>Ther Adv Psychopharmacol</source>. <year>2013</year>;<volume>3</volume>:<fpage>101</fpage>–<lpage>113</lpage><pub-id pub-id-type="pmid">24167681</pub-id></mixed-citation>
    </ref>
    <ref id="B97">
      <label>97</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dagliati</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Marinoni</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cerra</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group><article-title>Integration of administrative, clinical, and environmental data to support the management of type 2 diabetes mellitus: From satellites to clinical care</article-title>. <source>J Diabetes Sci Technol</source>. <year>2016</year>;<volume>10</volume>:<fpage>19</fpage>–<lpage>26</lpage><pub-id pub-id-type="pmid">26630915</pub-id></mixed-citation>
    </ref>
    <ref id="B98">
      <label>98</label>
      <mixed-citation publication-type="web"><collab>Aetionomy Knowledge Base: Organising knowledge about neurodegenerative disease mechanisms for the improvement of drug development and therapy</collab>. <year>2015</year> Available online at <uri xlink:type="simple" xlink:href="http://aetionomy.scai.fhg.de">http://aetionomy.scai.fhg.de</uri> (last accessed <date-in-citation><month>4</month><day>25</day>, <year>2016</year></date-in-citation>)</mixed-citation>
    </ref>
    <ref id="B99">
      <label>99</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rujan</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hoefkens</surname><given-names>J</given-names></name></person-group><article-title>A collaborative approach to develop a multi-omics data analytics platform for translational research</article-title>. <source>Appl Transl Genomics</source>. <year>2014</year>;<volume>3</volume>:<fpage>105</fpage>–<lpage>108</lpage></mixed-citation>
    </ref>
  </ref-list>
  <ref-list>
    <p><bold>Cite this article as:</bold> Satagopam V, Gu W, Eifes S, Gawron P, Ostaszewski M, Gebel S, Barbosa-Silva A, Balling R, Schneider R (2016) Integration and visualization of translational medicine data for better understanding of human diseases. <italic>Big Data</italic> 4:2, 97–108, DOI: 10.1089/big.2015.0057.</p>
  </ref-list>
  <sec id="s020">
    <title/>
    <fn-group>
      <fn id="fn1" fn-type="other">
        <label>
          <sup>*</sup>
        </label>
        <p><bold>Clinical data:</bold> Data collected by the characterization of a biomedical research participant by a medical professional, for example, demographics, study-specific questionnaires, or examinations. <bold>Molecular data:</bold> Data collected by analyzing samples donated by a biomedical research participant using imaging (microscopy) or high-throughput molecular profiling (“omics”).</p>
      </fn>
      <fn id="fn2" fn-type="other">
        <label>
          <sup>†</sup>
        </label>
        <p><bold>“omics”:</bold> Technologies for characterization and quantification of entire pools of biological molecules in a given sample. Data sets generated using omics are highly dimensional, ranging from hundreds to hundreds of thousands of variables per sample. The name “omics” encompasses particular readout methods: genomics (entire genome), transcriptomics (entire gene expression profile), proteomics (entire protein expression profile), metabolomics (entire pool of metabolites), and others.</p>
      </fn>
      <fn id="fn3" fn-type="other">
        <label>
          <sup>‡</sup>
        </label>
        <p><bold>Cohort:</bold> A group of people with a shared characteristic. Here, a group of subjects with demographic, clinical, or other characteristics relevant for translational research.</p>
      </fn>
      <fn id="fn4" fn-type="other">
        <label>
          <sup>§</sup>
        </label>
        <p><bold>Molecular interaction networks:</bold> A class of graphs, where nodes represent various biomolecules, and edges represent interactions between them.</p>
      </fn>
      <fn id="fn5" fn-type="other">
        <label>
          <sup>**</sup>
        </label>
        <p>Available at <uri xlink:type="simple" xlink:href="http://r3lab.uni.lu/web/tgm-pipeline">http://r3lab.uni.lu/web/tgm-pipeline</uri></p>
      </fn>
      <fn id="fn6" fn-type="other">
        <label>
          <sup>††</sup>
        </label>
        <p>Code available on the project website, <uri xlink:type="simple" xlink:href="http://r3lab.uni.lu/web/tgm-pipeline">http://r3lab.uni.lu/web/tgm-pipeline</uri></p>
      </fn>
      <fn id="fn7" fn-type="other">
        <label>
          <sup>‡‡</sup>
        </label>
        <p>In the PD map: <uri xlink:type="simple" xlink:href="http://tgm-pipeline.uni.lu/minerva/?search=%22TF%20NR4A2%22">http://tgm-pipeline.uni.lu/minerva/?search=%22TF%20NR4A2%22</uri></p>
      </fn>
      <fn id="fn8" fn-type="other">
        <label>
          <sup>§§</sup>
        </label>
        <p>In the PD map: <uri xlink:type="simple" xlink:href="http://tgm-pipeline.uni.lu/minerva/?search=reaction:re720">http://tgm-pipeline.uni.lu/minerva/?search=reaction:re720</uri></p>
      </fn>
      <fn id="fn9" fn-type="other">
        <label>
          <sup>***</sup>
        </label>
        <p>In the PD map: <uri xlink:type="simple" xlink:href="http://tgm-pipeline.uni.lu/minerva/?search=IL1%20receptor%20complex,purinergic%20receptor">http://tgm-pipeline.uni.lu/minerva/?search=IL1%20receptor%20complex,purinergic%20receptor</uri></p>
      </fn>
    </fn-group>
  </sec>
  <glossary>
    <title>Abbreviations Used</title>
    <def-list>
      <def-item>
        <term id="G1">API</term>
        <def>
          <p>application programming interface</p>
        </def>
      </def-item>
      <def-item>
        <term id="G2">ETL</term>
        <def>
          <p>Extract, Transform, and Load</p>
        </def>
      </def-item>
      <def-item>
        <term id="G3">eTRIKS</term>
        <def>
          <p>European Translational Information and Knowledge Management Services</p>
        </def>
      </def-item>
      <def-item>
        <term id="G4">GEO</term>
        <def>
          <p>Gene Expression Omnibus</p>
        </def>
      </def-item>
      <def-item>
        <term id="G5">GSW</term>
        <def>
          <p>Galaxy Server Workspace</p>
        </def>
      </def-item>
      <def-item>
        <term id="G6">HPC</term>
        <def>
          <p>high-performance computing</p>
        </def>
      </def-item>
      <def-item>
        <term id="G7">IMI</term>
        <def>
          <p>Innovative Medicines Initiative</p>
        </def>
      </def-item>
      <def-item>
        <term id="G8">PD</term>
        <def>
          <p>Parkinson's disease</p>
        </def>
      </def-item>
      <def-item>
        <term id="G9">SBGN</term>
        <def>
          <p>Systems Biology Graphical Notation</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
</back>
